Innovent receives NMPA approval for Taletrectinib Adipate capsule from NMPA
DOVBLERON marks the 13th addition to Innovent’s commercial portfolio
DOVBLERON marks the 13th addition to Innovent’s commercial portfolio
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
The company's portfolio includes 21 commercialized products, 19 approved ANDAs, 4 CGT designations, 6 filed ANDAs, and 45 products in its pipeline
Cenexi is committed to working closely with the ANSM to address the observations
Puri is an accomplished leader and financial sector veteran with over four decades of experience
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
The investment will empower RDHL to develop a virtual diagnostic and care platform, expanding access to healthcare for underserved communities
Subscribe To Our Newsletter & Stay Updated